Lethal Injection

Montana Judge Puts Executions on Hold

On October 6, Montana District Court Judge Jeffrey Sherlock (pictured) held that the state's proposed lethal injection protocol violated state law, which requires that an "ultra fast-acting barbiturate" be used in executions. Judge Sherlock said the proposed barbiturate, pentobarbital, does not qualify as such a drug. The ruling stated, "The State of Montana is hereby enjoined from using the drug pentobarbital in its lethal injection protocol unless and until the statute authorizing lethal injection is modified in conformance with this decision." In 2012, a judge struck down Montana's three-drug protocol because it differed from the two-drug protocol called for in state law. As a result of the most recent ruling, executions in Montana will continue to be on hold indefinitely. “The State has had multiple opportunities to correct the problems with the death penalty protocol. And each time they came up with a new flawed procedure,” said ACLU Legal Director Jim Taylor. “Seven years of litigation has demonstrated that Montana's death penalty is broken beyond repair." Montana has carried out three executions since 1976, the last of which was in 2006. Earlier in 2015, a bill to repeal the death penalty failed on a tie vote in the House of Representatives.

Arkansas Inmates Seek Stay of 8 Executions; Say New Secrecy Law Violates Settlement Agreement

Eight death-row prisoners whom Arkansas has scheduled to be executed in the next four months have asked a judge to issue a preliminary injunction that would put their executions on hold. They argue that the state's execution procedures are unconstitutional for multiple reasons and that Arkansas' secrecy law violates a previous settlement agreement between death row inmates and the state. Arkansas, which has not carried out an execution since November 2005, has scheduled eight executions for four dates (two executions on each date) between October of this year and January 2016, even though legal challenges to the constitutionality of the state's execution procedures were pending in state court and were scheduled to proceed to trial. The state recently passed a bill that allows the Department of Correction to keep the source of execution drugs secret. Jeff Rosenzweig, an attorney for the death row inmates, said the secrecy law violates an agreement in which the state agreed to tell inmates the source of lethal injection drugs in exchange for the inmates dropping part of a prior lawsuit challenging the state's execution protocol. The inmates argue that, without knowing the manufacturer of the drugs, they cannot determine whether the execution may constitute cruel and unusual punishment. They are seeking a preliminary injunction blocking executions from proceeding until the case is decided. A state trial court has moved the hearing date for the inmates' lawsuit from October 23 to October 7. In June 2012, the Arkansas Supreme Court struck down the state's prior execution law as violating the state constitution. [UPDATE: On October 9, the Arkansas trial court judge who is presiding over the inmates' challenge to the state's execution process granted a temporary restraining order staying all of the scheduled executions. The court ruled that the prisoners would suffer "immediate and irreparable injury" if they were executed and that proceeding with the executions, without affording the parties an adequate opportunity for discovery and to resolve the legal issues in the case "will rob Plaintiffs of an opportunity to litigate their rights under the Arkansas Constitution."]

Virginia Executes Inmate with Appeal Still Pending Before Supreme Court

On October 1, Virginia executed Alfredo Prieto (pictured) before the U.S. Supreme Court had decided whether to grant a stay on his challenge to Virginia's use of an execution drug obtained from Texas Department of Criminal Justice. Robert Lee, Prieto's attorney, said, "The Justices of the Supreme Court of the United States were considering Mr. Prieto’s request for a stay of execution but the Virginia Department of Corrections went ahead with the execution without waiting for a decision from the Justices." Earlier in the day, U.S. District Court Judge Henry Hudson held a hearing on a challenge to Virginia's lethal injection procedure. Virginia used compounded pentobarbital obtained from Texas, without any inquiry into the manufacture, purity, or storage of the drug. Prieto's lawyers raised questions about the safety and efficacy of the drug. Hudson denied the appeal and lifted a preliminary injunction that had put the execution on hold. The U.S. Court of Appeals for the 4th Circuit denied Prieto's appeal of this issue. Prieto's lawyers then filed a petition for review with the U.S. Supreme Court, but Virginia carried out the execution before the Court could issue a decision. The last time a state executed an inmate with appeals still pending was January 29, 2014, when Missouri executed Herbert Smulls.

Another Drug Company Opposes Use of Its Product in Executions

Sun Pharma, which is based in India, has publicly dissociated itself from the use of its drugs in upcoming Arkansas executions. The company said it prohibits the sale of its products to entities that might use them for killing. Sun Pharma was notified of the possible misuse of its products by the Associated Press, which had obtained redacted photographs of the drugs Arkansas planned to use in eight scheduled executions. A recently passed secrecy law allows the state to withhold the source of its execution drugs from public scrutiny. (Virginia's Supreme Court also recently shielded some information about executions from the public.) Other companies whose drugs might be used by Arkansas have also objected. Hikma Pharmaceuticals said it was investigating whether Arkansas had obtained midazolam from one of its subsidiaries, and Hospira, which was identified as a possible source of the potassium chloride that Arkansas plans to use, was one of the first companies to bar its drugs from executions.

Nebraska's Attempt to Import Execution Drug Halted in India

A shipment of sodium thiopental, an anesthetic once widely used in executions, was recently stopped in India before it could reach Nebraska. The Indian distributor sold more than $50,000 worth of sodium thiopental to the state in May, but the shipment was stopped before leaving the country because of "improper or missing paperwork." FedEx said it halted the shipment because it did not have Food And Drug Administration clearance: "As with any international importation of a drug, data about that shipment is transmitted to federal agencies in advance, including U.S. Customs and the Food and Drug Administration. If the shipment is authorized, we will deliver it to the recipient; if it is not, we will return it to the foreign shipper." Nebraska purchased the drugs despite the FDA's warning that importation of sodium thiopental for executions violates federal law. The FDA has consistently said that it will not allow execution drugs into the U.S. because the producers are not FDA-credited and the drugs are not approved for that purpose.

USA Today Chronicles Declining Death Penalty: It "May Be Living on Borrowed Time"

In a sweeping look at the current state of the U.S. death penalty, USA Today reporters Richard Wolf and Kevin Johnson highlight several recent story lines that collectively illustrate a dramatic decline in the country's use of capital punishment. Their conclusion: "The death penalty in America may be living on borrowed time." Wolf and Johnson recount recent cases in which high-profile crimes resulted in a life without parole sentence, in many instances because victims' families raised concerns about the painful emotional impact of a lengthy appeals process. Skeet Glover, whose father and stepmother were killed in Texas, explained his family's support for a plea deal resulting in a life without parole sentence: "As a family, we were going to do this together. I couldn't help my dad anymore. I couldn't help (stepmother) Peggy ... and I didn't want to punish anyone else in the family...There are no regrets." The article also tells the stories of death row exonerees, including the seven men exonerated in the last two years after spending 30 years or more on death row, and persistent questions of innocence for inmates still facing execution. The story then turns to ongoing battles in courts and legislatures. It chronicles the difficulties surrounding lethal injection, from trade regulations and opposition from the medical community that has made it more difficult for states to obtain execution drugs to legal challenges against execution protocols. Legislative action has shown "a clear trend in favor of retreat or repeal," the article states, noting the seven states that have recently repealed capital punishment, and the four states where moratoriums are in place. (Click image to enlarge.)

Why Missouri is an Outlier in Execution Trends

As national execution numbers drop to historic lows and a growing number of states halt executions or repeal the death penalty altogether, Missouri has recently increased the number of executions it is carrying out and overtaken Texas for the highest per-capita execution rate. Missouri and Texas have carried out all of the last 15 executions in the U.S. and 80% of executions through September 1 of this year. A report by The Marshall Project explores why Missouri is bucking national trends, highlighting the availability of execution drugs, Missouri's political climate, and the lack of adequate defense resources. While shortages of lethal injection drugs have slowed executions in many states, Missouri has managed to stockpile pentobarbitral for use in executions. Because of state secrecy laws, the source of the drug is unknown, and state officials will not confirm whether the drug is produced by a compounding pharmacy or obtained from another source, such as a veterinary supplier or overseas manufacturer. The governor and attorney general of Missouri have pushed to move executions forward, using the death penalty to establish "tough-on-crime" credentials as Democrats in a politically conservative state. Courts have also contributed to the unusual situation in Missouri. The state Supreme Court, which sets execution dates, scheduled one execution per month to make up for holds due to drug shortages. Finally, underfunding and heavy caseloads have created what defense attorneys are calling a "crisis" in capital representation. Missouri was ranked 49th of the 50 states in per-capita spending on indigent defense in 2009. In March, the American Bar Association Death Penalty Assessment Team told the Missouri Supreme Court, "The current pace of executions is preventing counsel for the condemned from performing competently. "

Major European Pension Fund Divests from Pharmaceutical Company Linked to Executions

The Dutch public employees' pension fund, Stichting Pensioenfonds ABP (ABP), has divested from the pharmaceutical company Mylan after learning that the Virginia Department of Corrections had supplies of one of Mylan's products in stock for use in executions. A spokesman for ABP - which with net assets of $416 billion is the world's third largest pension fund - said, "As the Dutch government and Dutch society as a whole renounced the death penalty a long time ago, we do not want Dutch pension money to be involved in that." Although Mylan states on its website that its products are not intended for use in executions, fund managers were not satisfied with the company's measures to keep the drugs out of lethal injections. ABP held €25 million shares in Mylan in 2014, but began selling them off during 9 months of unfruitful discussions with the company. ABP says it sold its remaining €9 million ($10 million) Mylan holdings in full because "We thought we have only one step left to show our disapproval." The divestment is part of ongoing efforts by European officials to discourage executions in the U.S., which the European Union regards as a human rights violation. European companies are banned from exporting drugs for use in executions, and several European drug companies have put distribution restrictions in place to stop their products from being used in lethal injection.

Pages